cyc 202 has been researched along with Fibrosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Airik, M; Airik, R; Conlon, PJ; Dorman, A; Huynh, AB; McCourt, BT; Murray, SL; Phua, YL; Rush, BM; Tan, RJ; Vockley, J | 1 |
| He, X; Liu, W; Wang, S; Zhang, Y; Zhao, H; Zhao, X; Zhou, Y | 1 |
| Haylor, J; Khwaja, A; Nutter, F | 1 |
| Bai, X; Geng, J; Hou, X; Li, X; Tian, J | 1 |
| Feghali-Bostwick, CA; Robinson, AR; Steinman, RA | 1 |
5 other study(ies) available for cyc 202 and Fibrosis
| Article | Year |
|---|---|
Persistent DNA damage underlies tubular cell polyploidization and progression to chronic kidney disease in kidneys deficient in the DNA repair protein FAN1.
Topics: Animals; DNA Damage; DNA Repair; Endodeoxyribonucleases; Exodeoxyribonucleases; Fibrosis; Humans; Kidney; Mice; Mice, Knockout; Multifunctional Enzymes; Nephritis, Interstitial; Renal Insufficiency, Chronic; Roscovitine | 2022 |
Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-β1/p38 MAPK pathway.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney; Kidney Function Tests; Male; Mice, Inbred Strains; p38 Mitogen-Activated Protein Kinases; Roscovitine; Signal Transduction; Streptozocin; Transforming Growth Factor beta | 2019 |
Seliciclib inhibits renal hypertrophy but not fibrosis in the rat following subtotal nephrectomy.
Topics: Albuminuria; Animals; Cyclin A1; Cyclin-Dependent Kinase 2; Disease Progression; Extracellular Matrix; Fibrosis; Glomerulosclerosis, Focal Segmental; Hypertension; Hypertrophy; Kidney; Nephrectomy; Purines; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Roscovitine | 2012 |
CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway.
Topics: Adult; Animals; Cell Line; Cyclin-Dependent Kinase 5; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Female; Fibrosis; Glucose; Humans; Kidney Tubules; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; PPAR gamma; Protein Kinase Inhibitors; Purines; Rats, Sprague-Dawley; Roscovitine; Signal Transduction | 2016 |
Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.
Topics: Animals; Collagen; Connective Tissue Growth Factor; Fibroblasts; Fibronectins; Fibrosis; Humans; Interleukin-6; Mice; NIH 3T3 Cells; Phosphorylation; Purines; Roscovitine; Scleroderma, Systemic; Signal Transduction; STAT3 Transcription Factor; Transcription, Genetic; Transforming Growth Factor beta; Up-Regulation | 2012 |